Search

everythinglearnresearchcommunity

for

Search:↓

Oral paclitaxel plus encequidar improved tumor response and caused less neuropathy but more serious infections than intravenous paclitaxel.

Vitamin D3 and its receptor help protect skin from UVB-related cancer.

Deuruxolitinib significantly helps regrow scalp hair in adults with moderate to severe alopecia areata.

Ritlecitinib successfully treated a child's alopecia universalis after baricitinib failed.

Baricitinib treatment helps regrow eyebrow, eyelash, and scalp hair in severe alopecia areata, improving patients' emotional well-being and quality of life.

Topical tofacitinib is a safe and effective treatment for autoimmune skin disorders.

Oral tofacitinib may be an effective and tolerable treatment for some people with severe alopecia areata.

Baricitinib helps regrow hair in severe alopecia areata and is safe, but more research is needed.

taVNS reduces vitiligo symptoms in mice.

Reducing the dose of Baricitinib to 2mg still helped over half of the patients with severe scalp alopecia maintain their hair regrowth after two years.

The conclusion is that a new test was created to find substances that affect specific ion channels, and it works well for drug discovery.

Applying 2% tofacitinib cream helped some children with severe hair loss grow back hair.

Ritlecitinib effectively reduces severe hair loss in alopecia areata over 24 months.

Tofacitinib may help treat severe hair loss, but more research is needed.

Stopping mitochondrial respiration can prevent brain cancer spread in skin cancer patients, and plant compound β-sitosterol could help achieve this.

ATP helps prevent skin damage from vandetanib by reducing stress.

Tofacitinib can regrow hair in alopecia areata patients, but some may experience flares during treatment.

Topical tofacitinib may effectively and safely regrow facial hair in some people with alopecia areata.

Avemar may help in cancer treatment, but its effectiveness isn't proven yet.

Ritlecitinib may cause serious side effects like blood clots in alopecia areata patients.

Tigason improved hair growth in a boy with monilethrix without side effects.

Most adverse reactions to the treatment were mild, with nausea being the most common.

Abemaciclib can cause skin, hair, and nail problems, leading some patients to stop using it.

Vismodegib can cause muscle spasms, taste changes, hair loss, fatigue, weight loss, and possibly new issues like skin cancer, dehydration, and swallowing problems, needing close monitoring.

A new treatment called deucravacitinib helped a patient with severe hair loss grow their hair back quickly.

Ritlecitinib effectively regrows and maintains scalp, eyebrow, and eyelash hair in alopecia areata patients.

Switching to generic tacrolimus was safe, effective, and saved money.

Oral valganciclovir improved a patient's skin condition caused by immunosuppression.

Leflunomide successfully treated a rare skin condition in a liver transplant patient.